The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
The language of chromatin modification in human cancers
Open accessAbstract
The genetic information of human cells is stored in the context of chromatin, which is subjected to DNA methylation and various histone modifications. Such a ‘language’ of chromatin modification constitutes a fundamental means of gene and (epi)genome regulation, underlying a myriad of cellular and developmental processes. In recent years, mounting evidence has demonstrated that miswriting, misreading or mis-erasing of the modification language embedded in chromatin represents a common, sometimes early and pivotal, event across a wide range of human cancers, contributing to oncogenesis through the induction of epigenetic, transcriptomic and phenotypic alterations. It is increasingly clear that cancer-related metabolic perturbations and oncohistone mutations also directly impact chromatin modification, thereby promoting cancerous transformation. Phase separation-based deregulation of chromatin modulators and chromatin structure is also emerging to be an important underpinning of tumorigenesis. Understanding the various molecular pathways that underscore a misregulated chromatin language in cancer, together with discovery and development of more effective drugs to target these chromatin-related vulnerabilities, will enhance treatment of human malignancies. Deregulation of chromatin modification underlies a myriad of oncogenic processes. This Review synthesizes the many connections between chromatin modifications and cancer, discussing recent advances and highlighting options for therapeutic targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–274 of 274
Qiu, Y., Liu, L., Zhao, C., Han, C., Li, F., Zhang, J., Wang, Y., Li, G., Mei, Y., Wu, M., et al. (2012) · Genes & Development · doi:10.1101/gad.188359.112 · Cited by 134
Hsu, C.-C., Shi, J., Yuan, C., Zhao, D. Y., Jiang, S., Lyu, J., Wang, X., Li, H., Wen, H., Li, W., et al. (2018) · Genes & Development · doi:10.1101/gad.303784.117 · Cited by 133
Structure of nucleosome-bound DNA methyltransferases DNMT3A and DNMT3B
Xu, T.-H., Liu, M., Zhou, X. E., Liang, G., Zhao, G., Xu, H. E., Melcher, K., & Jones, P. A. (2020) · Nature · doi:10.1038/s41586-020-2747-1 · Cited by 133
Targeting EZH2 and PRC2 dependence as novel anticancer therapy
Xu, B., Konze, K. D., Jin, J. J., & Wang, G. G. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.001 · Cited by 129
Self-citationDorrance, A. M., Liu, S., Yuan, W., Becknell, B., Arnoczky, K. J., Guimond, M., Strout, M. P., Feng, L., Nakamura, T., Yu, L., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25546 · Cited by 128
Bronner, C., Alhosin, M., Hamiche, A., & Mousli, M. (2019) · Genes · doi:10.3390/genes10010065 · Cited by 123
TET family dioxygenases and the TET activator vitamin C in immune responses and cancer
Yue, X., & Rao, A. (2020) · Blood · doi:10.1182/blood.2019004158 · Cited by 123
Hashwah, H., Schmid, C. A., Kasser, S., Bertram, K., Stelling, A., Manz, M. G., & Mueller, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619555114 · Cited by 121
Mammalian ALKBH1 serves as an N6-mA demethylase of unpairing DNA
Zhang, M., Yang, S., Nelakanti, R. V., Zhao, W., Liu, G., Li, Z., Liu, X., Wu, T., Xiao, A., & Li, H. (2020) · Cell Research · doi:10.1038/s41422-019-0237-5 · Cited by 117
Epigenomic Reprogramming as a Driver of Malignant Glioma
Phillips, R. E., Soshnev, A. A., & Allis, C. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.008 · Cited by 116
Self-citationRegulation of the Dot1 histone H3K79 methyltransferase by histone H4K16 acetylation
Valencia‐Sánchez, M. I., Ioannes, P. D., Wang, M., Truong, D. M., Lee, R., Armache, J., Boeke, J. D., & Armache, K. (2021) · Science · doi:10.1126/science.abc6663 · Cited by 114
Genetic and epigenetic determinants of diffuse large B-cell lymphoma
Bakhshi, T. J., & Georgel, P. T. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-00389-w · Cited by 111
Structural Insights into Histone Crotonyl-Lysine Recognition by the AF9 YEATS Domain
Zhang, Q., Zeng, L., Zhao, C., Ju, Y., Konuma, T., & Zhou, M. (2016) · Structure · doi:10.1016/j.str.2016.05.023 · Cited by 110
Structure-guided development of YEATS domain inhibitors by targeting π-π-π stacking
Li, X., Li, X.-M., Jiang, Y., Liu, Z., Cui, Y., Fung, K. Y., van der Beelen, S. H. E., Tian, G., Wan, L., Shi, X., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0144-y · Cited by 110
Self-citationHistone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression
Jain, S. U., Khazaei, S., Marchione, D. M., Lundgren, S. M., Wang, X., Weinberg, D. N., Deshmukh, S., Juretic, N., Lü, C., Allis, C. D., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006076117 · Cited by 108
Self-citationHistone H3K23-specific acetylation by MORF is coupled to H3K14 acylation
Klein, B. J., Jang, S. M., Lachance, C., Mi, W., Lyu, J., Sakuraba, S., Krajewski, K., Wang, W., Sidoli, S., Liu, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12551-5 · Cited by 106
Meyer, S. E., Qin, T., Muench, D. E., Masuda, K., Venkatasubramanian, M., Orr, E., Suarez, L., Gore, S. D., Delwel, R., Paietta, E. M., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0008 · Cited by 105
Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice
García‐Ramírez, I., Tadros, S., González‐Herrero, I., Martín‐Lorenzo, A., Rodríguez-Hernández, G., Moore, D. Y., Ruiz-Roca, L., Blanco, Ó., Alonso‐López, D., Rivas, J. D. L., et al. (2017) · Blood · doi:10.1182/blood-2016-08-733469 · Cited by 105
An allosteric interaction links USP7 to deubiquitination and chromatin targeting of UHRF1.
Zhang, Z.-M., Rothbart, S. B., Allison, D. F., Cai, Q., Harrison, J. S., Li, L., Wang, Y., Strahl, B. D., Wang, G. G., & Song, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.046 · Cited by 99
Self-citationMiyazaki, H., Higashimoto, K., Yada, Y., Endo, T. A., Sharif, J., Komori, T., Matsuda, M., Koseki, Y., Nakayama, M., Soejima, H., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003897 · Cited by 99
MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours
Perlman, E. J., Gadd, S., Arold, S. T., Radhakrishnan, A., Gerhard, D. S., Jennings, L. J., Huff, V., Auvil, J. M. G., Davidsen, T. M., Dome, J. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms10013 · Cited by 98
The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target
Martile, M. D., Bufalo, D. D., & Trisciuoglio, D. (2016) · Oncotarget · doi:10.18632/oncotarget.10048 · Cited by 97
BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis
Fan, H., Lu, J., Guo, Y., Li, D., Zhang, Z., Tsai, Y., Pi, W., Ahn, J. H., Gong, W., Xiang, Y., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00729-3 · Cited by 97
Self-citationHistone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis
Shi, L., Shi, J., Shi, X., Li, W., & Wen, H. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.014 · Cited by 95
NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
Brennan, K., Shin, J. H., Tay, J. K., Prunello, M., Gentles, A. J., Sunwoo, J. B., & Gevaert, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-17298-x · Cited by 94
Structure of H3K36-methylated nucleosome–PWWP complex reveals multivalent cross-gyre binding
Wang, H., Farnung, L., Dienemann, C., & Cramer, P. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0345-4 · Cited by 93
Jang, S., Kang, C., Yang, H.-S., Jung, T., Hebert, H., Chung, K. Y., Kim, S. J., Hohng, S., & Song, J. (2019) · Genes & Development · doi:10.1101/gad.323790.118 · Cited by 92
Gough, S. M., Lee, F., Yang, F., Walker, R. L., Zhu, Y. J., Pineda, M. A., Onozawa, M., Chung, Y. J., Bilke, S., Wagner, E. K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0419 · Cited by 90
Self-citationEnhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
Maitituoheti, M., Keung, E. Z.-Y., Tang, M., Liang, Y., Alam, H., Han, G., Singh, A. K., Raman, A. T., Terranova, C. J., Sarkar, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108293 · Cited by 90
DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias
Yang, L., Rodriguez, B. A. T., Mayle, A., Park, H. J., Lin, X., Luo, M., Jeong, M., Curry, C. V., Kim, S.-B., Ruau, D., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.015 · Cited by 89
Structural basis for impairment of DNA methylation by the DNMT3A R882H mutation
Anteneh, H., Fang, J., & Song, J. (2020) · Nature Communications · doi:10.1038/s41467-020-16213-9 · Cited by 89
Mutations in the BAF-Complex Subunit DPF2 Are Associated with Coffin-Siris Syndrome
Vasileiou, G., Vergarajauregui, S., Endele, S. U., Popp, B., Büttner, C., Ekici, A. B., Gérard, M., Bramswig, N. C., Albrecht, B., Clayton‐Smith, J., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.01.014 · Cited by 88
Guo, C., Che, Z., Yue, J., Xie, P., Hao, S., Xie, W., Luo, Z., & Lin, C. (2020) · Science Advances · doi:10.1126/sciadv.aay4858 · Cited by 86
Chemical strategies to overcome resistance against targeted anticancer therapeutics
Pisa, R., & Kapoor, T. M. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0596-8 · Cited by 86
Histone benzoylation serves as an epigenetic mark for DPF and YEATS family proteins
Ren, X., Zhou, Y., Xue, Z., Hao, N., Li, Y., Guo, X., Wang, D., Shi, X., & Li, H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1130 · Cited by 83
N6-methyladenine in DNA antagonizes SATB1 in early development
Li, Z., Zhao, S., Nelakanti, R. V., Lin, K., Wu, T., Alderman, M. H., Guo, C., Wang, P., Zhang, M., Wang, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2500-9 · Cited by 82
Self-citationOncogenic Mechanisms of Histone H3 Mutations
Weinberg, D. N., Allis, C. D., & Lü, C. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026443 · Cited by 78
Self-citationDukatz, M., Holzer, K., Choudalakis, M., Emperle, M., Lungu, C., Bashtrykov, P., & Jeltsch, A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.09.006 · Cited by 78
Cryo-EM structure of the human MLL1 core complex bound to the nucleosome
Park, S. H., Ayoub, A. M., Lee, Y., Xu, J., Kim, H., Zheng, W. H., Zhang, B., Liang, S., An, S., Zhang, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13550-2 · Cited by 72
Emperle, M., Adam, S., Kunert, S., Dukatz, M., Baude, A., Plass, C., Rathert, P., Bashtrykov, P., & Jeltsch, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz911 · Cited by 70
Solid tumours hijack the histone variant network
Ghiraldini, F. G., Filipescu, D., & Bernstein, E. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-020-00330-0 · Cited by 69
Swaroop, A., Oyer, J. A., Will, C., Huang, X., Yu, W., Troche, C., Bulic, M., Durham, B. H., Wen, Q. J., Crispino, J. D., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0474-y · Cited by 68
Structural insights into the π-π-π stacking mechanism and DNA-binding activity of the YEATS domain
Klein, B. J., Vann, K. R., Andrews, F. H., Wang, W., Zhang, J., Zhang, Y., Beloglazkina, A. A., Mi, W., Li, Y., Li, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07072-6 · Cited by 66
Ferreira, H. J., Heyn, H., Vizoso, M., Moutinho, C., Vidal, E., Gómez, A., Martínez‐Cardús, A., Simó‐Riudalbas, L., Morán, S., Jost, E., et al. (2015) · Oncogene · doi:10.1038/onc.2015.359 · Cited by 65
Woodcock, C. B., Yu, D., Hajian, T., Li, J., Huang, Y., Dai, N., Junior, I. R. C., Wu, T., Vedadi, M., Zhang, X., et al. (2019) · Cell Discovery · doi:10.1038/s41421-019-0136-4 · Cited by 65
Suganuma, T., & Workman, J. L. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012634 · Cited by 60
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Vogelmann, A., Robaa, D., Sippl, W., & Jung, M. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.01.010 · Cited by 60
Structural basis of nucleic acid recognition and 6mA demethylation by human ALKBH1
Tian, L., Liu, Y., Chen, L., Tang, Q., Wu, W., Sun, W. D., Chen, Z., & Yan, X. (2020) · Cell Research · doi:10.1038/s41422-019-0233-9 · Cited by 59
Mapping chromatin modifications at the single cell level
Ludwig, C., & Bintu, L. (2019) · Development · doi:10.1242/dev.170217 · Cited by 57
Histone Acetyltransferase Activity of MOF Is Required for MLL-AF9 Leukemogenesis
Valerio, D. G., Xu, H., Chen, C.-W. D., Hoshii, T., Eisold, M. E., Delaney, C. D., Cusan, M., Deshpande, A. J., Huang, C., Lujambio, A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2374 · Cited by 56
DNMT3A reads and connects histone H3K36me2 to DNA methylation
Xu, W., Li, J., Rong, B., Zhao, B., Wang, M., Dai, R., Chen, Q., Liu, H., Gu, Z., Liu, S., et al. (2019) · Protein & Cell · doi:10.1007/s13238-019-00672-y · Cited by 56
Detecting and interpreting DNA methylation marks
Ren, R., Horton, J. R., Zhang, X., Blumenthal, R., & Cheng, X. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.06.004 · Cited by 53
Biochemical and structural basis for YTH domain of human YTHDC1 binding to methylated adenine in DNA
Woodcock, C. B., Horton, J. R., Zhou, J., Bedford, M. T., Blumenthal, R., Zhang, X., & Cheng, X. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa604 · Cited by 51
PHF20 Readers Link Methylation of Histone H3K4 and p53 with H4K16 Acetylation
Klein, B. J., Wang, X., Cui, G., Yuan, C., Botuyan, M. V., Lin, K., Lu, Y., Wang, X., Zhao, Y., Bruns, C. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.056 · Cited by 50
Vlaming, H., McLean, C. M., Korthout, T., Alemdehy, M. F., Hendriks, S., Lancini, C., Palit, S. A. L., Klarenbeek, S., Kwesi‐Maliepaard, E. M., Molenaar, T. M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2019101564 · Cited by 44
Recruitment of Gcn5-containing Complexes during c-Myc-dependent Gene Activation
Flinn, E. M., Wallberg, A. E., Hermann, S., Grant, P. A., Workman, J. L., & Wright, A. P. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201704200 · Cited by 42
Li, J., Galbo, P. M., Gong, W., Storey, A. J., Tsai, Y., Yu, X., Ahn, J. H., Guo, Y., Mackintosh, S. G., Edmondson, R. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21357-3 · Cited by 41
Self-citationKDM5ヒストンデメチラーゼ活性は細胞トランスクリプトームの不均一性を治療抵抗性に関連付ける【JST・京大機械翻訳】
Kunihiko, H., Wu, H., Sebastien, V., Thomas, O., Kyomi, J. I., Kimiyo, N. Y., Thomas, M. L., Fassl, A., Shawn, B., Papanastasiou, M., et al. (2018) · Cancer Cell · Cited by 39
Transcriptional Activation of MYC-Induced Genes by GCN5 Promotes B-cell Lymphomagenesis
Farria, A. T., Plummer, J. B., Salinger, A. P., Shen, J., Lin, K., Lu, Y., McBride, K. M., Koutelou, E., & Dent, S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2379 · Cited by 36
Cardin, S., Bilodeau, M., Roussy, M., Aubert, L., Milan, T., Jouan, L., Rouette, A., Laramée, L., Gendron, P., Duchaine, J., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019030981 · Cited by 34
MLL fusion proteins and transcriptional control
Slany, R. K. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194503 · Cited by 34
Jiao, F., Li, Z., He, C., Xu, W., Yang, G., Liu, T., Shen, H., Cai, J., Anastas, J. N., Mao, Y. Q., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba2113 · Cited by 33
Lu, R., Wang, J., Ren, Z., Yin, J., Wang, Y., Cai, L., & Wang, G. G. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3275 · Cited by 32
Self-citationHuang, T., Piunti, A., Qi, J., Morgan, M. A., Bartom, E. T., Shilatifard, A., & Saratsis, A. M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01092-4 · Cited by 32
NUP98‐BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy
Roussy, M., Bilodeau, M., Jouan, L., Tibout, P., Laramée, L., Lemyre, E., Léveillé, F., Tihy, F., Cardin, S., Sauvageau, C., et al. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22532 · Cited by 30
Ueda, T., Nakata, Y., Nagamachi, A., Yamasaki, N., Kanai, A., Sera, Y., Sasaki, M., Matsui, H., Honda, Z., Oda, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600070113 · Cited by 29
Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion
Zhang, Y., Guo, Y., Gough, S. M., Zhang, J., Vann, K. R., Li, K., Cai, L., Shi, X., Aplan, P. D., Wang, G. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17098-4 · Cited by 29
Self-citationThe acute myeloid leukemia variant DNMT3A Arg882His is a DNMT3B-like enzyme
Norvil, A. B., AlAbdi, L., Liu, B., Tu, Y. H., Forstoffer, N. E., Michie, A. R., Chen, T., & Gowher, H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa139 · Cited by 28
Norvil, A. B., Petell, C. J., AlAbdi, L., Wu, L., Rossie, S. S., & Gowher, H. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00964 · Cited by 27
Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
Lu, R., & Wang, G. G. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00241 · Cited by 27
Self-citationZhang, H., Zhou, B. O., Su, Q., Xu, J., Harding, R., Tempel, W., Nayak, V., Li, Y., Loppnau, P., Dou, Y., et al. (2018) · Genes & Development · doi:10.1101/gad.311639.118 · Cited by 26
Histone isoforms and the oncohistone code
Flaus, A., Downs, J. A., & Owen‐Hughes, T. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.11.003 · Cited by 26
Clonal Hematopoiesis and Premalignant Diseases
Kaner, J. D., Desai, P. M., Mencia-Trinchant, N., Guzmán, M. L., Roboz, G. J., & Hassane, D. C. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035675 · Cited by 21
The big picture of chromatin biology by cryo-EM
Jang, S., & Song, J. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.05.017 · Cited by 19
Cited by
Signal pathways of melanoma and targeted therapy
Guo, W., Wang, H., & Li, C. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00827-6 · Cited by 379
So, J. Y., Ohm, J., Lipkowitz, S., & Yang, L. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108253 · Cited by 256
Spatially resolved epigenomic profiling of single cells in complex tissues
Lu, T., Ang, C. E., & Zhuang, X. (2022) · Cell · doi:10.1016/j.cell.2022.09.035 · Cited by 197
Dumetier, B., Sauter, C., Hajmirza, A., Pernon, B., Aucagne, R., Fournier, C., Row, C., Guidez, F., Rossi, C., Lepage, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10123101 · Cited by 9
Metadata
- Authors
- Zhao, S., Allis, C. D., & Wang, G. G.
- Venue
- Nature Reviews Cancer
- Published
- 2021-05-17
- Volume
- 21
- Issue
- 7
- Pages
- 413-430
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W3162117965
- Cited by
- 402
- References
- 274
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.